Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the …
PL Moro, X Yue, P Lewis, P Haber, K Broder - Vaccine, 2011 - Elsevier
BACKGROUND: Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged≥ 65 years, Vaccine Adverse Event Reporting System …
P Haber, PL Moro, C Ng, GM Dores, S Perez-Vilar… - Vaccine, 2020 - Elsevier
Abstract Introduction The Advisory Committee on Immunization Practices (ACIP)
recommends vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular …
recommends vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular …
Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population
HF Tseng, LS Sy, L Qian, SM Marcy… - Clinical infectious …, 2013 - academic.oup.com
Background. Published data on the safety of tetanus-diphtheria-acellular pertussis vaccine
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older …
Centers for Disease Control and … - MMWR: Morbidity & …, 2012 - search.ebscohost.com
Abstract Since 2005, the Advisory Committee on Immunization Practices (ACIP) has
recommended a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) …
recommended a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) …
US Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005–2007
S Chang, PM O'Connor, BA Slade, EJ Woo - Vaccine, 2013 - Elsevier
BACKGROUND: Pre-licensure clinical trials for two US licensed tetanus toxoid, reduced
diphtheria toxoid and acellular pertussis (Tdap) vaccines did not reveal any major safety …
diphtheria toxoid and acellular pertussis (Tdap) vaccines did not reveal any major safety …
FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine
Centers for Disease Control and … - MMWR. Morbidity …, 2011 - pubmed.ncbi.nlm.nih.gov
On July 8, 2011, the Food and Drug Administration (FDA) approved an expanded age
indication for the tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine …
indication for the tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine …
Safety surveillance of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines
PL Moro, S Perez-Vilar, P Lewis… - …, 2018 - publications.aap.org
OBJECTIVE: To assess the safety of currently licensed diphtheria-tetanus-acellular pertussis
(DTaP) vaccines in the United States by using data from the Vaccine Adverse Event …
(DTaP) vaccines in the United States by using data from the Vaccine Adverse Event …
[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …
FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …
Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): results of two randomized …
WM Weston, LR Friedland, X Wu, B Howe - Vaccine, 2012 - Elsevier
BACKGROUND: Pertussis can cause significant morbidity in elderly patients, who can also
transmit this disease to infants and young children. There is little data available on the use of …
transmit this disease to infants and young children. There is little data available on the use of …
Safety of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine in adults in Japan
M Ujiie, S Tsuzuki, M Suzuki, M Ota… - Japanese Journal of …, 2021 - jstage.jst.go.jp
抄録 Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is
generally used for booster vaccination of infants in Europe and the United States to avoid …
generally used for booster vaccination of infants in Europe and the United States to avoid …